Góngora RA

Language: Spanish
References: 10
Page: 255-258
PDF size: 27.59 Kb.

ABSTRACT

The ovarian hyperstimulation is an iatrogenic complication that is intimately tied up to the assisted reproduction therapies, without distinguishing among the different existence programs (heterologus and homologus inseminations, in vitro fertilization); this implies a series of changes at the hemodynamic level, with all the complications that this represents. The physical changes that are revealed are the ovarian diameter with asymptomatic manifestations in the light cases, and in the serious forms with an important blood imbalance with ascites, hydrothorax, arterial hypotension, tachycardia, haemoconcentration, oliguria, sodium retention, hyponatremia, increase of the renal plasmatic activity, hepatic malfunction and, in some extreme cases, renal inadequacy and thrombosis accidents. These changes make the doctor be in a delicate situation where the prevention would be the best weapon that they have.

REFERENCES

1. Chae HD, Park EJ, Kim SH, et al. Ovarian hyperstimulation syndrome complicating a spontaneous singleton pregnancy: a case report. J Assist Reprod Genet 2001; 18(2): 120-3.

2. Whelan JG III, Vlahos NF. The ovarian hyperstimulation syndrome. Fertil Steril 2000; 73: 883-96.

3. Golan A, Ron-El R, Herman A, Soffer Y, Weinraub Z, Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 1989; 44: 430-40.

4. Mathur RS, Akande AV, Keay SD, Hunt LP, Jenkins JM. Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril 2000; 73: 901-7.

5. Murdoch AP, Evbuomwan I. Severe complications of ovarian hyperstimulation syndrome are preventable. Hum Reprod 1999; 14: 2922-3.

6. Polishuk WZ, Schenker JG. Ovarian hyperstimulation syndrome. Fertil Steril 1969; 20: 443-50.

7. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertile Steril 1992; 58: 249-61.

8. Haning RV, Austin CW, Carlson IH. Plasma oestradiol is superior to ultrasound and urinary estriol glucuronide as a predictor of ovarian hyperstimulation during induction of ovulation with menotropins. Fertil Steril 1983; 40: 31-6.

9. Schwartz M, Jewelewicz R, Dyrenfurth I. The use of human menopausal and chorioni gonadotrophins for induction of ovulation. Ame J of Obstet and Gynec 1980; 138: 801-7.

10. Aboulghar MA, Mansour RT, Serour GI. Reduction of human menopausal gonadotrophins dose before coasting prevents severe ovarian hyperstimulaton syndrome with minimal cycle cancellation. J of Assisted Reprod and Genet 2000; 17: 298-301.